Literature DB >> 31230159

Serological survey and risk factors of Aelurostrongylus abstrusus infection among owned cats in Italy.

Maria Alfonsa Cavalera1, Manuela Schnyder2, Emily Katharina Gueldner2, Tommaso Furlanello3, Roberta Iatta1, Emanuele Brianti4, Christina Strube5, Vito Colella1,6, Domenico Otranto7.   

Abstract

Feline lungworms affect the respiratory tract of domestic cats causing respiratory conditions of various degrees. In this study, we investigated the exposure of cats to feline lungworm infections by detecting antibodies in a large population of animals from several regions of Italy. Sera of 1087 domestic cats living in regions of the north (n = 700), the centre (n = 227) and the south (n = 160) of Italy were examined by a newly developed indirect ELISA conceived for detection of antibodies against the most frequently occurring feline lungworm Aelurostrongylus abstrusus. Individual cat data (i.e., age, sex, neutering status and provenience) were analysed as potential risk factors for exposure to lungworm infections. Samples were additionally screened for feline leukaemia virus (FeLV) and feline immunodeficiency virus (FIV) proviral DNAs. Overall, 9% (98/1087; 95% confidence interval (CI) 7.4-10.9%) of the animals tested seropositive to lungworm antibodies. Positive cats were identified in the north (7.1%; CI 5.5-9.3%), in the centre (5.3%; CI 3.0-9.0%) and in the South (22.5%; CI 16.7-29.6%), with more seropositive animals in the latter area (p < 0.05). The risk of lungworm infection in cats was significantly associated with age less than 6 months (i.e. 24.4%, p < 0.05) and FIV infection (p < 0.05). This large-scale serological survey confirms the exposure of cats to lungworm infections in Italy and that serological tests can be used to assess the distribution of lungworm infections in large populations of animals.

Entities:  

Keywords:  Aelurostrongylus abstrusus; Antibodies; Cat; ELISA; Italy; Lungworms; Prevalence

Mesh:

Substances:

Year:  2019        PMID: 31230159     DOI: 10.1007/s00436-019-06373-z

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  5 in total

1.  Efficacy of Bravecto® Plus spot-on solution for cats (280 mg/ml fluralaner and 14 mg/ml moxidectin) for the prevention of aelurostrongylosis in experimentally infected cats.

Authors:  Katharina Raue; Nadja Rohdich; Daniela Hauck; Eva Zschiesche; Simone Morelli; Donato Traversa; Angela Di Cesare; Rainer K A Roepke; Christina Strube
Journal:  Parasit Vectors       Date:  2021-02-16       Impact factor: 3.876

Review 2.  Cat Respiratory Nematodes: Current Knowledge, Novel Data and Warranted Studies on Clinical Features, Treatment and Control.

Authors:  Simone Morelli; Anastasia Diakou; Mariasole Colombo; Angela Di Cesare; Alessandra Barlaam; Dimitris Dimzas; Donato Traversa
Journal:  Pathogens       Date:  2021-04-10

3.  Aelurostrongylus abstrusus Infections in Domestic Cats (Felis silvestris catus) from Antioquia, Colombia.

Authors:  Sara Lopez-Osorio; Jeffer Leonardo Navarro-Ruiz; Astrid Rave; Anja Taubert; Carlos Hermosilla; Jenny J Chaparro-Gutierrez
Journal:  Pathogens       Date:  2021-03-13

4.  Do All Roads Lead to Rome? The Potential of Different Approaches to Diagnose Aelurostrongylus abstrusus Infection in Cats.

Authors:  Katharina Raue; Jonathan Raue; Daniela Hauck; Franz Söbbeler; Simone Morelli; Donato Traversa; Manuela Schnyder; Holger Volk; Christina Strube
Journal:  Pathogens       Date:  2021-05-14

5.  Prevalence and risk factors associated with cat parasites in Italy: a multicenter study.

Authors:  Marco Genchi; Alice Vismarra; Stefania Zanet; Simone Morelli; Roberta Galuppi; Giuseppe Cringoli; Riccardo Lia; Manuela Diaferia; Antonio Frangipane di Regalbono; Giulia Venegoni; Fabrizio Solari Basano; Antonio Varcasia; Stefania Perrucci; Vincenzo Musella; Emanuele Brianti; Alessia Gazzonis; Michele Drigo; Liliana Colombo; Laura Kramer
Journal:  Parasit Vectors       Date:  2021-09-15       Impact factor: 3.876

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.